200 Users Online
Defibrillator Market Segmentation by Type - S-ICD | T-ICD | Manual ED | Automated ED | Wearable Cardioverter Defibrillators
Newly-released Defibrillator Market analysis report by Persistence Market Research shows that global sales of the Defibrillator Market in 2021 were held at US$ 11.4 Bn. With 7.4%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth. Implantable Cardioverter Defibrillators (ICD) are expected to be the highest revenue-generating segment in the defibrillator market, projected to grow at a CAGR of over 7.4% during 2022 – 2032.
|
Attribute |
Details |
|
Global Defibrillator Market (2022) |
US$ 12.2 Bn |
|
Global Defibrillator Market (2032) |
US$ 24.9 Bn |
|
Global Defibrillator Market CAGR (2022 - 2032) |
7.4% |
|
U.S. Defibrillator Market (2032) |
US$ 9.3 Bn |
|
Key Companies Profiled |
|
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
As per the Defibrillator Market research by Persistence Market Research - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Defibrillator Market increased at around 6.7% CAGR.
The increased demand for implanted and external defibrillators is driving innovation in these devices. Subcutaneous and transvenous devices that aim to increase patient comfort are examples of implanted device innovation. In 2017, the Swedish Transport Agency undertook a pilot operation with the intention of distributing Automated External Defibrillators (AEDs) by drone. This will cut down the time it takes for an AED to be delivered, boosting the odds of survival. Defibrillation knowledge is promoted by regular training programs and public awareness campaigns, which indirectly raise demand for home care and public access defibrillators. As the demand for wearable cardioverter defibrillators develops, patients are more likely to use them as a temporary solution or as a bridge to a long-term implanted cardioverter defibrillator installation.
Dr. Harish Manyam from Erlanger Heart and Lung Center performed the nation's first double chamber implanted cardioverter defibrillator operation (ICD). This latest enhancement features MRI capability and Bluetooth connectivity, providing patients and healthcare providers to interact very efficiently.
The Erlanger cardiology team offers ICDs and cardiac resynchronization therapy defibrillator (CRT-D) devices to patients with abnormal heart rhythms and heart failure. The high-voltage devices include a smartphone app and Bluetooth connectivity for improved remote monitoring and communication, allowing physicians to tailor therapy to a patient's unique clinical needs. Defibrillators have come a long way in terms of price, size, and convenience of use. Because of being a consumer-friendly device, running a defibrillator has become simple for skilled users.
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized VersionGrowth in the incidence and frequency of cardiovascular disorders in established populations is expected to result in a large demand for effective defibrillator devices over the projected period. All such evolutions, which included the inclusion and in-house study of new flat-panel display devices, compact capacitors, adjustable defibrillator plates, high-density batteries, as well as embedded systems, primarily resulted in a machine that could be transported to a patient suspected of a heart attack in an ambulance.
As per the World Health Organization, cardiac diseases are the biggest cause of death globally. Cardiovascular diseases kill nearly 17.9 million people across the globe annually, accounting for nearly 31% of all mortality. In January 2022, an off-duty doctor in Sweden used an AED which was supplied via an autonomous drone to save the life of a 71-year-old patient, marking the Scandinavian country's first known successful rescue. Drone Delivery Canada has conducted studies in Ontario in recent years utilizing simulated cardiac arrest scenarios.
Which Region is projected to Offer the Largest Opportunity for the Defibrillator Market?
With the frequency of cardiovascular disorders on the rise, North America holds the world's largest market for defibrillators. Because of its sophisticated healthcare infrastructure and a more general understanding of the benefits of AEDs, North America has the most AEDs in public and private settings.
In 2020, heart disease was the leading cause of mortality for most men and women in the United States, with over 655,000 Americans dying each year. As the region's awareness of cardiovascular disease develops, the sector is expected to expand. Furthermore, key manufacturers such as Stryker, Abbott, and Boston Scientific Corporation, among others, are expected to boost the market through various commercialization activities such as collaborations, and product launches, and others in the field of both ICDs and external defibrillators. For instance, SYK has announced the introduction of its newest defibrillation solution, the LIFEPAK CR2 automated external defibrillator ("AED"), in the United States, in collaboration with the LIFELINKcentral AED program manager.
Sales Team
Client Partner
Which country leads the market for defibrillators in terms of revenue?
The United States is expected to account for the largest market share of US$ 9.3 billion by the end of 2032. The rising usage for external defibrillators in medical institutions and public places such as colleges, hotels, streets, trains, and other sites to prevent casualties from sudden cardiac arrest seems to be a significant factor driving the growth of the defibrillator market. According to the Centers for Disease Control and Prevention, around 6.1 million people have cardiac arrhythmias, or abnormal heartbeats. ICDs are commonly recommended to help avoid potentially fatal arrhythmias. In patients with heart failure or when the chambers of the heart pump out of sync, CRT-Ds would be used to recover the heart's regular rhythm of beating.
Zoll, a prominent US based producer of critical care equipment and systems that joined the Asahi Kasei Group in April 2012, is one of the top firms in Wearable Cardioverter Defibrillator. The LifeVest, a wearable defibrillator by ZOLL, is meant to continually monitor the heart and identify irregular cardiac rhythms. When the gadget detects a life-threatening arrhythmia, it sends a therapy shock to the patient's heart to restore normal rhythm.
Why Implantable Cardioverter Defibrillators (ICD) is projected to account for the largest market?
The implantable cardioverter defibrillator (ICD) market is predicted to account for around 70% share throughout the analysis period. The invention of automated external defibrillators (AEDs) and implanted cardioverter defibrillators (ICDs) are two of the most notable of these advancements. The market for implanted defibrillators is expected to rise due to technological improvements such as the introduction of quadripolar lead devices to enhance device programming and battery life, as well as the development of MRI-safe ICDs.
Furthermore, an increase in the prevalence of atrial fibrillation and the high risk of sudden cardiac arrest (SCA) is driving demand for implanted defibrillators. Because of the built-in vocal and visual support, as well as the combined Cardio-Pulmonary Resuscitation and defibrillator capabilities, people have been advised to use them in public and at home.
Because ICDs are available in a number of designs, including single-chambered, dual-chambered, subcutaneous, and MRI-safe, this increase is understandable. According to WHO, cardiovascular disorders are one of the leading causes of mortality worldwide. Cardiovascular illnesses claimed the lives of 17.7 million people in 2017. Furthermore, two-thirds of CVD-related deaths occurred in low- and middle-income nations. A significant majority of implanted cardioverter defibrillator (ICD) surgeries are performed in hospitals, clinics, and cardiac centers. Defibrillators can be found in critical care units (CCUs), intensive care units (ICUs), and emergency departments.
Furthermore, the emergence of subcutaneous ICD technology in 2012 changed cardiac rhythm management therapy techniques. The first commercially available S-ICDs system was Boston Scientific's S-ICDs, which received market approval in 2012. S-ICDs are popular as they are implanted beneath the skin and do not need the placement of leads within the heart. This increased demand for S-ICDs throughout the world, propelling the industry forward. The Atlas S-ICD study has revealed that the subcutaneously implanted defibrillator may reduce severe lead-related problems seen with a transvenous device.
Which Component of Defibrillator is expected to Score Highest Growth in the Coming Years?
Hospital commanded the largest revenue as well as CAGR of nearly 7.5%, during the forecast period. This is because the frequency of patient populations admitted to hospital and operations performed there has increased. Implantable cardioverter defibrillators (ICDs) & external defibrillators (EDDs) are widely being used in hospitals to treat patients who have had a cardiac arrest or other heart disorders. Hospitals, clinic, as well as cardiac centres accounted for 80.2 percent of the global defibrillator market in 2020.
Due to increased efforts to improve the availability of public access Automated External Defibrillator (AEDs), train personnel, and improve reaction to sudden cardiac arrest scenarios, the public access market sector is expected to rise at the fastest pace. Various tourist destinations, first-tier cities, and coastal districts in China have begun expedited AED deployment since 2019, according to the Global Times in January 2020.
In addition, Hangzhou was the first city in China to require the use of AEDs in airports, metro stations, police vehicles, ships, and other public areas. Early defibrillation, faster response time, ease of use, cost-effectiveness, and shortage of skilled people have all contributed to the demand for AEDs at hospitals.
What effect will Covid-19 have on the defibrillator market?
COVID-19 had a neutral influence on the market, particularly the ICDs market, resulting in lower demand and sales in 2020. The outbreak also impacted hospitals' buying capacities, particularly in small-scale institutions, causing supply deals to be canceled or postponed, impacting total revenue for all key defibrillator rivals. All of these concerns have a significant influence on the production and supply chain for defibrillators. Throughout the year, the spread of COVID-19 in a number of significant marketplaces created concern. Abbott, for example, reported growth in its hospital-based business in the second and third quarters of 2020. However, due to a significant spike of COVID-19 instances and hospitalizations in various countries, the trends had either levelled out which had been significantly harmed by the fourth quarter of 2020. Despite the pandemic's decreasing sales activity, Nihon Kohden showcased defibrillator sales growth in 2020.
Defibrillator Market companies are constantly upgrading and increasing their product offerings. Innovation of next-generation external defibrillators, which are expected to increase safety and efficacy, is expected to generate profitable prospects for the market.
Some of the recent developments by key defibrillator providers are as follows:
Similarly, the Persistence Market Research team has been keeping track of recent advancements in the field of defibrillator services, which are detailed in the complete research.
By Component
By Type
By End Use
By Region
The Defibrillator Market is worth more than US$ 11.4 Bn at present.
The value of the Defibrillator Market is projected to increase at a CAGR of around 7.4% during 2022 - 2032.
The value of the Defibrillator Market increased at a CAGR of around 6.7% during 2017 - 2021.
One of the key reasons projected to fuel market expansion during the forecast period is the global increase in the incidence and prevalence of cardiovascular diseases.
The market for Defibrillator Market in China is projected to expand at a CAGR of around 8.3% during 2022 - 2032.
While the market in South Korea is expected to grow at nearly 6.4%, the market in Japan is projected to register a CAGR of nearly 9.1% during 2022 - 2032.
